Publication: Chebulin: Terminalia chebula Retz. fruit-derived peptide with angiotensin-I-converting enzyme inhibitory activity
1
Issued Date
2015-11-01
Resource Type
ISSN
14708744
08854513
08854513
DOI
Other identifier(s)
2-s2.0-84955186378
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Biotechnology and Applied Biochemistry. Vol.62, No.6 (2015), 746-753
Suggested Citation
Thakorn Sornwatana, Kunan Bangphoomi, Sittiruk Roytrakul, Nuanchawee Wetprasit, Kiattawee Choowongkomon, Sunanta Ratanapo Chebulin: Terminalia chebula Retz. fruit-derived peptide with angiotensin-I-converting enzyme inhibitory activity. Biotechnology and Applied Biochemistry. Vol.62, No.6 (2015), 746-753. doi:10.1002/bab.1321 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/35356
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Chebulin: Terminalia chebula Retz. fruit-derived peptide with angiotensin-I-converting enzyme inhibitory activity
Abstract
© 2014 International Union of Biochemistry and Molecular Biology, Inc. Angiotensin-I-converting enzyme (ACE) plays an important role in blood pressure regulation. In this study, an ACE-hexapeptide inhibitor (Asp-Glu-Asn-Ser-Lys-Phe) designated as chebulin was produced from the fruit protein of Terminalia chebula Retz. by pepsin digestion, ultrafiltrated through a 3 KDa cut-off membrane, a reverse-phase high-performance liquid chromatography, and nano-liquid chromatography tandem mass spectrometry analysis. Chebulin was found to inhibit ACE in a noncompetitive manner, as supported by the structural model. It bounds to ACE by the hydrogen bond, hydrophobic and ionic interactions via the interactions of C-terminal Phe (Phe-6), and N-terminal residues (Asp-1 and Glu-2) with the amino acid residues on noncatalytic sites of the ACE. The results showed that chebulin derived from fruits of T. chebula Retz. is a potential ACE-peptide inhibitor that could be used as a functional food additive for the prevention of hypertension and as an alternative to ACE inhibitor drug.